Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme
Open Access
- 1 January 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (1) , 61-70
- https://doi.org/10.1093/jac/dkh512
Abstract
Objectives: As part of the SENTRY Antimicrobial Surveillance Programme, 383 non-replicative randomly collected Pseudomonas aeruginosa isolates were collected during 1999–2002. These strains originated from three geographically distinct hospitals within Italy: Genoa (Northern Italy); Rome and Catania (Sicily), and were further studied to identify the prevalence of metallo-β-lactamase (MβL) alleles across Italy and to determine their genetic details. Methods: Multidrug-resistant (MDR) strains were identified by MIC analysis followed by genotyping and PCR-based strategies. Results: Initial MIC analysis identified 31 MDR isolates that displayed an Etest MβL-positive phenotype. Of these, 25 produced either the MβL VIM-1 or IMP-13 as detected by PCR and sequencing. VIM-1-producing isolates were found at all sites, whereas IMP-13-producing isolates were only found in Rome. MβL-producing isolates were found at all Italian SENTRY sites and together amounted to 6.5% of all P. aeruginosa isolates. Genetic analysis indicated that many strains contained multiple integrons and identified two novel MβL integrons, one from the site in Genoa and one from Sicily. Integrons identical in structure and sequence to In70, the first identified and characterized blaVIM-containing integron from Verona, were found in isolates with distinct ribotypes at the Roman and Sicilian sites indicating that this integron has recently disseminated across Italy. All 25 MβL-producing isolates were genetically linked in that all isolates contained Tn5051 sequences and all harboured the insertion sequence IsPa7 which may be involved in the mobilization of these resistance alleles. Conclusions: Taken together, these results indicate that Italy has a nationwide problem of MDR P. aeruginosa produced by mobile MβL genes.Keywords
This publication has 29 references indexed in Scilit:
- First Isolation of bla VIM-2 in Latin America: Report from the SENTRY Antimicrobial Surveillance ProgramAntimicrobial Agents and Chemotherapy, 2004
- Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001)Journal of Antimicrobial Chemotherapy, 2004
- bla VIM-7 , an Evolutionarily Distinct Metallo-β-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United StatesAntimicrobial Agents and Chemotherapy, 2004
- Genetic characterization of a novel metallo- -lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programmeJournal of Antimicrobial Chemotherapy, 2003
- VIM- and IMP-Type Metallo-ß-lactamase–ProducingPseudomonasspp. andAcinetobacterspp. in Korean HospitalsEmerging Infectious Diseases, 2003
- Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance ProgramJournal of Antimicrobial Chemotherapy, 2003
- Nosocomial Infections Caused by Multidrug-Resistant Isolates of Pseudomonas putida Producing VIM-1 Metallo-β-LactamaseJournal of Clinical Microbiology, 2002
- Metallo-β-Lactamase VIM-2 in Clinical Isolates ofPseudomonas aeruginosafrom PortugalMicrobial Drug Resistance, 2002
- Carbapenemases: a problem in waiting?Current Opinion in Microbiology, 2000
- Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in FranceAntimicrobial Agents and Chemotherapy, 2000